Mobile Stroke Units: The Barriers to Timely tPA Administration in the US
Stroke is one of the leading causes of death in the United States, with over 795,000 cases yearly. In particular,
Stroke is one of the leading causes of death in the United States, with over 795,000 cases yearly. In particular,
Dapagliflozin reduces the risk for hospitalization among patients with nondialysis-dependent chronic kidney disease, a new analysis confirms. In a post
Rates of infective endocarditis (IE) and associated procedures have grown substantially in the United States (US) in recent years due
Parkinson disease (PD) and diabetes mellitus (DM) comorbidities are associated with more severe neuroaxonal damage, according to a letter published
Heparin for thromboembolism prophylaxis in hospitalized patients with acute heart failure (HF) administered within 24 hours of hospital admission is associated with
Fundus fluorescein angiography (FFA) and optical coherence tomography-angiography (OCT-A) demonstrate similar consistencies for diagnosing diabetic retinopathy (DR), but post-panretinal photocoagulation